Rachel Thomson, MD

Rachel Thomson, MD

Director, Mycobacterial Diseases
Gallipoli Medical Research Institute
University of Queensland
Brisbane, QLD, Australia

Related Videos

Real World Case Management: Evaluating and Managing Patients with Advanced MAC Lung Disease/Refractory Features Video

Real World Case Management: Evaluating and Managing Patients with Advanced MAC Lung Disease/Refractory Features

Focus on Indications for and Optimizing Regimen Adherence with Novel Inhaled Antimicrobial Formulations

From Landmark Trials to Evidence-Based Therapy for Resistant, Refractory, High Risk and/or Challenging Patients with MAC Lung Infection Video

From Landmark Trials to Evidence-Based Therapy for Resistant, Refractory, High Risk and/or Challenging Patients with MAC Lung Infection

The Role, Safety, Indications, Evidence, and Efficacy of Novel, Inhaled Antimicrobial Formulations